Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation. Connolly SJ, Karthikeyan G, Ntsekhe M, Haileamlak A, et al. N Engl J Med 2022 Aug 28. doi: 10.1056/NEJMoa2209051.

Read + Share

Amedeo Smart

Independent Medical Education

Connolly SJ, Karthikeyan G, Ntsekhe M, Haileamlak A, et al. Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation. N Engl J Med 2022 Aug 28. doi: 10.1056/NEJMoa2209051.
PMID: 36036525